Premium
Letter: distinct hepatitis B virus relapse rates after discontinuing tenofovir and entecavir therapy in chronic hepatitis B patients
Author(s) -
Huang Rui,
Yao Renling,
Wu Weihua,
Wang Jian,
Wu Chao
Publication year - 2019
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.15150
Subject(s) - entecavir , medicine , tenofovir , chronic hepatitis , hepatitis b virus , gastroenterology , virology , hepatitis a virus , hepatitis b , virus , lamivudine , oncology , human immunodeficiency virus (hiv)